Neuralink Reports Success in 2nd Implant Trial with No Thread Issues

Photo : Reuters

California – Elon Musk's brain technology company, Neuralink, has announced a promising development in its ongoing trials. The startup reported that its advanced implant, which aims to enable paralyzed individuals to control digital devices purely through thought, has shown significant success in its second patient.

Neuralink's latest update reveals that the patient, known as Alex, has not encountered the "thread retraction" problems experienced by Noland Arbaugh, the first patient who received the implant in January. Arbaugh's implant faced issues where the tiny wires used in the device retracted after surgery, leading to a noticeable reduction in the number of electrodes capable of measuring brain signals. Although the threads have since stabilized for Arbaugh, this issue prompted Neuralink to take action.

The company acknowledged that they were aware of these complications from their animal trials. To address the problem and improve outcomes, Neuralink implemented several new strategies for the second patient. These included reducing the movement of the brain during the surgical procedure and minimizing the gap between the implant and the brain's surface.

Stay informed with the latest news. Follow DXB News Network on WhatsApp Channel 

The enhancements appear to be effective, as Neuralink reported that Alex has been able to use the device without encountering the previous issues. The second patient has already begun using the implant to play video games, explore 3D object design, and perform other tasks, marking a significant step forward for the technology.

Neuralink’s device is designed to assist individuals with spinal cord injuries by offering new ways to interact with digital environments. The progress with Alex provides a hopeful outlook for the technology's future applications and its potential to enhance the quality of life for user